$1.69
0.010.60%
Pre-Market: 8:17 AM EDT
Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics | -$0.38 | -$0.22 | — | — | $22.00K | $4.17K | — | — | 05/12/2025 | Get Alert |
ALLO | Allogene Therapeutics | -$0.51 | -$0.34 | -$0.28 | 17.65% | $21.00K | $14.00K | $0.00 | -100.00% | 03/13/2025 | Get Alert |
ALLO | Allogene Therapeutics | -$0.37 | -$0.33 | -$0.32 | 3.03% | $43.00K | $10.00K | $0.00 | -100.00% | 11/07/2024 | Get Alert |
ALLO | Allogene Therapeutics | -$0.53 | -$0.35 | -$0.35 | 0.00% | $44.00K | $20.00K | $0.00 | -100.00% | 08/07/2024 | Get Alert |
ALLO | Allogene Therapeutics | -$0.68 | -$0.41 | -$0.38 | 7.32% | $30.00K | $10.00K | $22.00K | 120.00% | 05/13/2024 | Get Alert |
ALLO | Allogene Therapeutics | -$0.67 | -$0.45 | -$0.43 | 4.44% | $26.00K | $20.00K | $21.00K | 5.00% | 03/14/2024 | Get Alert |
ALLO | Allogene Therapeutics | -$0.58 | -$0.52 | -$0.37 | 28.85% | $49.00K | $10.00K | $43.00K | 330.00% | 11/02/2023 | Get Alert |
ALLO | Allogene Therapeutics | -$0.52 | -$0.59 | -$0.53 | 10.17% | $86.00K | $70.00K | $44.00K | -37.14% | 08/02/2023 | Get Alert |
ALLO | Allogene Therapeutics | -$0.56 | -$0.62 | -$0.68 | -9.68% | $61.00K | $10.00K | $52.00K | 420.00% | 05/03/2023 | Get Alert |
ALLO | Allogene Therapeutics | -$0.54 | -$0.70 | -$0.66 | 5.71% | $51.00K | $60.00K | $47.00K | -21.67% | 02/28/2023 | Get Alert |
ALLO | Allogene Therapeutics | -$0.57 | -$0.64 | -$0.58 | 9.38% | $49.00K | $10.00K | $49.00K | 390.00% | 11/02/2022 | Get Alert |
ALLO | Allogene Therapeutics | -$0.53 | -$0.61 | -$0.52 | 14.75% | $44.00K | $10.00K | $86.00K | 760.00% | 08/09/2022 | Get Alert |
ALLO | Allogene Therapeutics | -$0.25 | -$0.58 | -$0.56 | 3.45% | $38.34M | — | $61.00K | — | 05/04/2022 | Get Alert |
ALLO | Allogene Therapeutics | -$0.53 | -$0.60 | -$0.54 | 10.00% | $0.00 | -$10.00K | $51.00K | 610.00% | 02/23/2022 | Get Alert |
ALLO | Allogene Therapeutics | -$0.52 | -$0.56 | -$0.57 | -1.79% | $0.00 | $10.00K | $49.00K | 390.00% | 11/04/2021 | Get Alert |
ALLO | Allogene Therapeutics | -$0.53 | -$0.55 | -$0.53 | 3.64% | $0.00 | — | $44.00K | — | 08/04/2021 | Get Alert |
ALLO | Allogene Therapeutics | -$0.50 | -$0.46 | -$0.25 | 45.65% | $0.00 | $13.92M | $38.34M | 175.47% | 05/05/2021 | Get Alert |
ALLO | Allogene Therapeutics | -$0.58 | -$0.56 | -$0.53 | 5.36% | $0.00 | $3.17M | $0.00 | -100.00% | 02/25/2021 | Get Alert |
ALLO | Allogene Therapeutics | -$0.50 | -$0.54 | -$0.52 | 3.70% | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
ALLO | Allogene Therapeutics | -$0.41 | -$0.54 | -$0.53 | 1.85% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
ALLO | Allogene Therapeutics | -$0.32 | -$0.58 | -$0.50 | 13.79% | $0.00 | — | $0.00 | — | 05/06/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-13 | $-0.28 | $-0.34 | 17.6 % |
Q3 | 2024-11-07 | $-0.32 | $-0.33 | 3.03 % |
Q2 | 2024-08-07 | $-0.35 | $-0.35 | 0.00 % |
Q1 | 2024-05-13 | $-0.38 | $-0.41 | 7.32 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-13 | $0 | $14.00K | -100.0 % |
Q3 | 2024-11-07 | $0 | $10.00K | -100.0 % |
Q2 | 2024-08-07 | $0 | $20.00K | -100.0 % |
Q1 | 2024-05-13 | $22.00K | $10.00K | 120.0 % |
Allogene Therapeutics (ALLO) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
The Actual EPS was $-0.28, which beat the estimate of $-0.34.
The Actual Revenue was $0K, which missed the estimate of $14K.
Browse earnings estimates, EPS, and revenue on all stocks.